James Robinson (biopharmacist)

Robinson began his career as a biochemical engineer with G.D. Searle and worked at various companies before becoming the head of technical support for Merck's vaccine, biologics and sterile manufacturing in 2010.^[2][3]

In 2017, Robinson began serving on CEPI's scientific advisory board. He was made vice-chair in 2019.^[3]

On February 16, 2022, Robinson was awarded a two-year, $340,000 grant by the Arnold Ventures Foundation to study biosimilars to determine potential cost savings from wider use of them.^[4]